Catheter ablation of ventricular extrasystoles and ventricular tachycardia in the elderly

被引：2

作者：

Halbfaß P. ^{[1
,3
]}

Nentwich K. ^{[1
]}

Sonne K. ^{[1
]}

Ene E. ^{[1
]}

Fochler F. ^{[1
]}

Mügge A. ^{[2
]}

Schieffer B. ^{[3
]}

Deneke T. ^{[1
,2
]}

机构：

[1] Klinik für Interventionelle Rhythmologie, Herz- und Gefäßklinik GmbH Bad Neustadt, Salzburger Leite 1, Bad Neustadt a. d. Saale

[2] Bergmannsheil Bochum, Ruhr-Universität Bochum, Bochum

[3] Uniklinik Marburg, Marburg

来源：

Herzschrittmachertherapie + Elektrophysiologie | 2017年 / 28卷 / 1期

关键词：

Catheter ablation; Efficacy; Quality of life; Safety; Ventricular tachycardia;

D O I：

10.1007/s00399-017-0483-5

中图分类号：

学科分类号：

摘要：

Background: The prevalence of structural heart disease increases with higher age, and thereby the basis for ventricular arrhythmias is created. Catheter ablation has been shown to be an effective therapy option that is very safe and achieves good long-term results in patients with recurrent ventricular tachycardia (VT). Data regarding ablation in patients older than 75 years is sparse, although this patient group was included as a minority in most published VT ablation studies. Data from younger patient collectives may not be transferable to older patient cohorts due to differences in patient comorbidities and baseline characteristics. Methods: Studies with patient collectives ≥75 years or even ≥80 years show comparable efficacy of catheter ablation for VT; however, the complication rate is higher, mainly due to groin complications, increases. Catheter ablation of ischemic VT appears effective and safe even in ≥75 year olds; however, extensive data for other structural heart diseases are lacking. Epicardial procedures are also possible and safe in older patients (≥80 years). Due to the significant challenges of VT ablation in older patients, including the consideration of complex comorbidities, these should be performed in specialized centers with high expertise. Conclusion: The aim of catheter ablation in older patients is, above all, to improve quality of life and morbidity. Long-term survival is significantly lower due to the “near end of life” situation than in younger patients. Careful consideration of alternative therapy options, chances for success of the catheter ablation, and their risks, taking into account specific patient conditions and symptoms, is crucial in these patients. © 2017, Springer Medizin Verlag Berlin.

引用

页码：9 / 15

页数：6

共 18 条

[1]

Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., Et al., Heart disease and stroke statistics – 2015 update. A report form the American Heart Association, Circulation, 131, pp. e29-e322, (2015)

[2]

Schron E.B., Exner D.V., Yao Q., Jenkins L.S., Steinberg J.S., Cook J.R., Kutalek S.P., Friedman P.L., Bubien R.S., Page R.L., Powell J., Quality of life in the antiarrhythmics versus implantable defbrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks, Circulation, 105, pp. 589-594, (2002)

[3]

Moss A.J., Greenberg H., Case R.B., Zareba W., Hall W.J., Brown M.W., Dauber J.P., McNitt S., Andrews M.L., Elkin A.D., Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator, Circulation, 110, pp. 3760-3765, (2004)

[4]

Hachiya H., Hirao K., Sasaki T., Higuchi K., Hayashi T., Tanaka Y., Kawabata M., Isobe M., Novel ECG predictor of difficult cases of outflow tract ventricular tachycardia: peak deflection index on an inferior lead, Circ. J., 74, pp. 256-261, (2010)

[5]

Tanaka Y., Tada H., Ito S., Naito S., Higuchi K., Kumagai K., Hachiya H., Hirao K., Oshima S., Taniguchi K., Aonuma K., Isobe M., Gender and age differences in candidates for radiofrequency catheter ablation of idiopathic ventricular arrhythmias, Circ J, 75, pp. 1585-1591, (2011)

[6]

Priori S.G., Blomstrom-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J., Elliott P.M., Titzsimons D., Hatala R., Hindricks G., Kirchhof P., Kjeldsen K., Kuck K.-H., Madrid A.H., 2015 ESC Guidelines fort he management of patients with ventricular arrhythmias and eht prevention of suddenc cardiac death, Eur Heart J, 36, pp. 2793-2867, (2015)

[7]

Epstein A.E., Kay G.N., Plumb V.J., McElderry H.A.T., Doppalapudi H., Yamada T., Safiroff J., Syed Z.A., Shkurovich S., Implantable cardioverter-defibrillator prescription in the elderly, Heart Rhythm, 6, pp. 1136-1143, (2009)

[8]

Reddy V.Y., Reynolds M.R., Neuzil P., Richardson A.W., Taborsky M., Jongnarangsin K., Kravolec S., Sediva L., Ruskin J.N., Josephson M.E., Prophylactic catheter ablation for the prevention of defibrillator therapy, N Engl J Med, 357, pp. 2657-2665, (2007)

[9]

Kuck K.-H., Schaumann A., Eckardt L., Willems S., Ventura R., Delacretaz E., Pitschner H.-F., Kautzner J., Schumacher B., Hansen P.S., Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomized controlled trial, Lancet, 375, pp. 31-40, (2010)

[10]

Palaniswamy C., Kolte D., Harikrishnan P., Khera S., Aronow W.S., Eugenio P., Lessner S., Ferrick A., Fonarow G.C., Ahmed A., Cooper H.A., Frishman W.H., Panza J.A., Iwai S., Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States, Heart Rhythm, 11, pp. 2056-2063, (2014)

← 1 2 →